
Merlintrader Trading Pub
Biotech catalyst, news and analysis PDUFA tracker

Merlintrader Trading Pub
Biotech catalyst, news and analysis PDUFA tracker
AI transparency: articles and reports are produced with the help of artificial intelligence and checked through a process that does not constitute specialist validation. They may contain errors: verify relevant information with independent sources. Read the full disclaimer.
Nov 4, 2026, 12:20 AM ET
Palladyne AI says one soldier can coordinate 200 drones, a scale not publicly tested
Nasdaq: $PDYNEmbodied autonomyBacklog conversionCash burn and dilution
PDYN Stock Hub: Palladyne AI News, Autonomy and the Revenue Test
Autonomy projects meet an existing hardware and engineering business. Backlog conversion and the cost of delivery determine whether growth can reduce cash consumption. The October 29 regular-session close was $3.68 (-6.84% versus October 28).
Full research report · PDF
Palladyne AI ($PDYN), research as of October 29, 2026
15 pages covering the existing long-form research, with the business, operating milestones, financial resources, dilution, ownership, risks, scenarios, sources and FAQ. This is a dated research snapshot; the hub follows later developments. For personal use only: redistribution prohibited.
Next scheduled financial checkpoint
November 10, 2026 · 8:00 a.m. ET
The company will discuss third-quarter financial and operational results. The October 29 announcement gives the call date, without quarterly results. Company announcement
SwarmShot joint development and Army evaluation are conditional program milestones. Neither a development collaboration nor a finalist selection establishes procurement revenue.
PDYN stock at a glance
Close · October 29, 2026
$3.68
Regular-session close; -6.84% versus $3.95 on October 28.
SHORT INTEREST
6.08M
Nasdaq, settlement October 15, 2026; about 12.3% of the July 29 share count (Merlintrader calculation) · Source
Where Palladyne AI stands now
Cash, cash equivalents and marketable securities were $43.746 million at June 30, 2026, against $47.055 million at the end of 2025. In the same six months the company used a calculated $21.290 million in operations and capital expenditure and raised approximately $17.8 million gross by selling 2,531,336 shares through its at-the-market program. Backlog rose from $17.3 million at March 31 to $24.6 million at June 30, while the share count moved from 46,117,164 at the end of 2025 to 49,338,510 on July 29. The order book is growing; so is the share base that has financed it. Source Source Source
Revenue growth needs to reduce cash consumption and support value per share.
The adverse case is a timing mismatch. Staff, equipment and development expenditures are paid before customers accept systems or expand orders. Delayed procurement or integration then pushes revenue out while expenses continue. At June 30, 2026, the company had $43.746 million of cash and marketable securities, but its historical first-half burn rate implies only about 12.3 months of static coverage. That calculation is a sensitivity, not management’s forecast of the date cash will run out. Source
The constructive case
The constructive case starts with a real delivery business. Palladyne reported $24.6 million of backlog at June 30, 2026, and approximately $13 million of new awards during the quarter, against quarterly revenue of $5.783 million. Management reiterated 2026 revenue guidance of $24–27 million on August 6. That gives the company work to execute rather than a thesis resting entirely on demonstrations. The next improvement would be a combination of deliveries, repeat orders and lower cash consumption as the enlarged business absorbs its operating costs. Source Source
The cautious case
The adverse case is a timing mismatch. Staff, equipment and development expenditures are paid before customers accept systems or expand orders. Delayed procurement or integration then pushes revenue out while expenses continue. At June 30, 2026, the company had $43.746 million of cash and marketable securities, but its historical first-half burn rate implies only about 12.3 months of static coverage. That calculation is a sensitivity, not management’s forecast of the date cash will run out. Source
Latest Palladyne AI news
Nov 4, 2026
Palladyne AI says one soldier can coordinate 200 drones, a scale not publicly tested
Palladyne AI claims that a single soldier can coordinate 200 drones. This scale has not been publicly tested. Not confirmed by a company release or filing at the time of writing; to be verified.
Oct 29, 2026
Third-quarter results call set for November 10 at 8:00 a.m. ET
Palladyne AI announced on October 29, 2026 that it will host a conference call on Tuesday, November 10, 2026, at 8:00 a.m. Eastern Time to discuss its financial and operational results for the third quarter ended September 30, 2026. The webcast will be archived for one year in the Investor section of the company’s website. The notice sets the date of the call; it does not include any figures, and the August 6 outlook of sequential third-quarter revenue growth and lower cash burn through the rest of 2026 remains the benchmark to test.
Oct 7, 2026
SwarmShot: joint counter-drone development with Federal Ammunition and Mossberg
Palladyne AI, Federal Ammunition and Mossberg launched joint development of SwarmShot, a modular system meant to turn compatible drones into reusable air-to-air interceptors operating as a collaborative swarm. Palladyne supplies the Gremlin-X quadcopter and its IntelliSwarm autonomy (BRAIN avionics plus SwarmOS); Federal designs the counter-drone shotshell and Mossberg the airborne weapon module. No financial terms, schedule or customer were disclosed: it is a development program, not an order.
Oct 6, 2026
BRAIN selected as a finalist in the Army xTech|Apex Intercept competition
Palladyne AI said its BRAIN edge AI flight computer was selected as a finalist in the U.S. Army FUZE xTech|Apex Intercept competition, run with Capability Program Executive Defensive Fires. Finalists demonstrate to Army and Department of War evaluators at a finals event expected in October or November 2026. A finalist slot is not a contract award.
Sep 24, 2026
legacy SPAC warrants expire
The 20,549,453 deSPAC warrants outstanding at June 30 expired on September 24; Nasdaq signed the Form 25 removing the warrant class on September 25 and it was filed on September 28. The common shares are not affected.
Sep 8, 2026
FANUC America collaboration
The partners plan industrial-robot integration and customer validation. The release gives no quantified purchase commitment.
PDYN stock catalysts and operating watchpoints
- November 10, 2026 · 8:00 a.m. ET — Third-quarter financial and operational results conference call. Scheduled company call
- October–November 2026 expected window — Army xTech finals evaluation described in the October 6 announcement; no completed outcome asserted. Conditional evaluation window
- Through March 2027 — Military-exercise invitations in the existing research; participation does not guarantee procurement. Program watchpoint
Company announcement; Company announcement; Company or primary reference; Company or primary reference
Backlog, options and the revenue needed in the second half
The final June 30, 2026 backlog was $24.6 million. It supersedes the approximately $24 million preliminary figure discussed in July. The final quarterly release also reported approximately $13 million of new contract awards during the June quarter. The company expected most of the backlog to convert to revenue over the following 12–18 months, so it cannot all be treated as revenue due before the end of 2026. Three months earlier, the March-quarter report had put backlog at $17.3 million and expected most of it to be recognized over the next 12 months; the June figure is about 42% higher on Merlintrader’s calculation from the rounded amounts (the company states 43%), while the conversion window quoted by the company has lengthened. Source Source
The definition matters: backlog includes committed contracts and purchase orders, both funded and unfunded, less revenue already recognized. It is a better indication of actual commercial work than a partnership announcement, but it is not a cash balance. Delivery, funding and customer acceptance can affect when the work produces revenue and when that revenue becomes cash. Source
Cash, monthly burn and the runway calculation
At June 30, 2026, Palladyne reported $33.774 million of cash and cash equivalents and $9.972 million of marketable securities, a combined $43.746 million. The securities were U.S. Treasury securities. The comparable combined balance at December 31, 2025 was $47.055 million. Cash alone rose during the first half partly because securities matured; that internal change does not represent new customer cash generation. Source
For the six months ended June 30, 2026, cash used in operations was $20.401 million and purchases of property and equipment were $0.889 million. Adding those amounts gives $21.290 million, or approximately $3.548 million per month. This uses management’s definition of operating cash burn: operating cash outflow plus capital expenditure. The $0.100 million received from selling equipment is shown separately and has not been used to reduce this calculation. Source Source
Merlintrader Health Score · $PDYN
2.65out of 5
Assessed October 5, 2026. Weighted calculation: 3.0×30% + 3.0×30% + 2.0×20% + 2.5×10% + 2.0×10% = 2.65. This describes financial and operational robustness over twelve to eighteen months, not an investment recommendation.
Red flags
- Financial balances retain their reporting dates and are not current cash.
- Milestone guidance is conditional; execution, collection and per-share outcomes remain separate tests.
PDYN Stock FAQ: Palladyne AI Questions Answered
When is the next PDYN stock catalyst?
Palladyne AI schedules its Q3 2026 financial and operational results call for November 10, 2026 at 8 a.m. ET. The next report will update revenue, backlog, cash use and commercial progress for its autonomy products. Results-call announcement.
How much revenue does Palladyne AI make?
Palladyne AI reported $5.783 million revenue for the quarter ended June 30, 2026 from hardware, development contracts and engineering services; software product sales had not begun. Backlog was $24.6 million, including funded and unfunded commitments, with most expected to convert over 12–18 months rather than entirely in 2026. Revenue and backlog. Quarterly operating update.
How much cash does Palladyne AI have, and how long will it last?
Palladyne AI held $43.746 million cash and marketable securities at June 30, 2026, covering about 12.3 months at its historical first-half spending rate. That calculation uses $20.401 million operating outflow plus $0.889 million capex, or approximately $3.548 million monthly. Future delivery timing and spending can change that coverage. Cash and spending. Operating update.
Is PDYN stock at risk of dilution?
Yes: Palladyne AI sold 2,531,336 ATM shares for approximately $17.8 million gross proceeds in the first half of 2026. Common shares increased from 46,117,164 at year-end 2025 to 49,338,510 at July 29. Further equity sales, awards and outstanding instruments can expand ownership dilution. Share issuance and capital structure.
When does Palladyne AI report earnings?
Palladyne AI schedules its Q3 2026 financial and operational results conference call for November 10, 2026 at 8 a.m. ET. The October 29 scheduling announcement provides the call date, with quarterly results still to come. Earnings-call schedule.
What does Palladyne AI do?
Palladyne AI develops autonomy software for industrial robots and uncrewed aircraft, alongside hardware, product-development and engineering services. Its platforms aim to help machines perceive their surroundings, adapt to tasks and cooperate with other vehicles; commercialization is still developing. Company operations. Product development.
Did Palladyne AI’s September notice delist PDYN common shares?
No: the Nasdaq Form 25 signed September 25 and filed September 28, 2026 applies only to Palladyne AI’s warrant class. Legacy deSPAC warrants expired September 24. Common shares and the separate 2024 insider warrants are different securities. Warrant-class delisting notice. Other warrant terms.
Does Palladyne AI’s FANUC agreement include a large purchase order?
Palladyne AI’s September 8, 2026 FANUC announcement describes strategic collaboration and customer validation, without a quantified purchase commitment. It is intended to advance deployment and adoption of autonomy software through industrial-robot applications. Collaboration announcement.
Primary sources
- Palladyne AI — Form 10-Q, quarter ended June 30, 2026, filed August 6
- Palladyne AI — Form 10-Q, quarter ended March 31, 2026, filed May 5
- Palladyne AI — Form 10-K for 2025, filed March 5, 2026
- Palladyne AI — second-quarter 2026 results, August 6, 2026
- Palladyne AI and FANUC America — collaboration, September 8, 2026
- Palladyne AI and NORDA Dynamics — planned integration, August 26, 2026
- Palladyne AI and Orkid Tech — fixed-wing collaboration, August 19, 2026
- Palladyne AI — GuideTech selling-stockholder resale registration, January 9, 2026
- Nasdaq — Form 25 removal of the Palladyne warrant class, signed September 25, filed September 28, 2026
- CEO — Form 4 purchase on September 8, 2026
- Significant shareholder — Schedule 13D amendment, May 14, 2026
- Palladyne AI — definitive proxy, April 22, 2026
- Nasdaq — PDYN short interest by settlement date, as of October 29, 2026
- Nasdaq — PDYN historical closing prices, October 28, 2026 close
- BlackRock, Inc. — Schedule 13G, filed July 29, 2026 (as of June 30, 2026)
- Palladyne AI — Form 8-K on the IAI memorandum of understanding, June 8, 2026
- Palladyne AI — Form 8-K on the 2026 annual meeting results, June 8, 2026
- Palladyne AI — preliminary second-quarter 2026 results, July 8, 2026
- Chief technology officer — Form 4, sell-to-cover, August 21, 2026
- Chief legal officer — Form 4, sell-to-cover, August 21, 2026
- Chief financial officer — Form 4, sell-to-cover, August 21, 2026
- Palladyne AI — SwarmOS at Project Convergence Capstone 6, August 6, 2026
- Palladyne AI — defense advisory board appointment, August 10, 2026
- Palladyne AI — investor conferences, August 31, 2026
- Palladyne AI — investor-relations press-release list, as of October 5, 2026
- Palladyne AI — BRAIN selected as finalist in the U.S. Army FUZE xTech|Apex Intercept competition, October 6, 2026
- Palladyne AI — Federal Ammunition, Mossberg and Palladyne AI launch joint development of SwarmShot, October 7, 2026
- Palladyne AI — third-quarter 2026 results conference call and webcast, October 29, 2026
Disclaimer. This content is published by Merlintrader for educational and informational purposes only. It is independent journalism and research. It does not constitute investment advice, an investment recommendation, an offer or a solicitation to buy or sell any security, and it is not a research report within the meaning of applicable United States securities regulation. Nothing here should be read as a recommendation to buy, sell or hold $PDYN or any other security.
Figures are taken from public filings with the U.S. Securities and Exchange Commission, company press releases and market-data providers, and are stated with their reference dates. Data can change without notice, and figures published before a results release become outdated the moment that release is issued. Merlintrader makes no representation that the information is complete or current at the time of reading. Readers should verify every figure against the primary source before acting on it.
Defense, space and technology companies carry procurement, execution, regulatory and financing risks. Government orders can be delayed or cancelled, production can exceed budget, export restrictions can limit sales, and acquisitions may fail to produce the expected returns. Contract announcements do not guarantee profitable deliveries or cash collection. Additional borrowing or equity issuance can increase obligations or dilute existing shareholders. Investors can lose part or all of their capital. Every reader is responsible for their own decisions and should consult a licensed financial adviser where appropriate.
Merlintrader may hold positions in securities mentioned. Some links on this page are affiliate or referral links, including those to Finviz and Stocktwits, which may generate a commission at no cost to the reader. Full legal information is available on the disclaimer and terms of use and privacy pages.



